Lymphangioleiomyomatosis Treatments
Find Lymphangioleiomyomatosis Treatments
Medications for Lymphangioleiomyomatosis
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Lymphangioleiomyomatosis.
Found 1 Approved Drug for Lymphangioleiomyomatosis
SIrolimus
Brand Names
Fyarro, Hyftor
SIrolimus
Brand Names
Fyarro, Hyftor
Form: Gel, Injection, Tablet, Solution
Method of administration: Oral, Intravenous, Topical
FDA approval date: January 07, 2014
Classification: mTOR Inhibitor Immunosuppressant
FYARRO ™ is indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa). FYARRO is an mTOR inhibitor indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa). ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances